The incidence of type 2 diabetes mellitus in the Philippines: A 9-year cohort study

被引:27
作者
Soria, Maria Luz B. [1 ]
Sy, Rody G. [2 ]
Vega, Bernard S.
Ty-Willing, Tommy
Abenir-Gailardo, Angela [3 ]
Velandria, Felicidad [4 ]
Punzalan, Felix Eduardo [2 ]
机构
[1] Univ Philippines, Dept Clin Epidemiol, CVI, CSMC,MDH, Quezon City 1101, Philippines
[2] Univ Philippines, PGH, Quezon City 1101, Philippines
[3] Univ Philippines, Coll Publ Hlth, Quezon City 1101, Philippines
[4] Food & Nutr Inst, Manila, Philippines
关键词
Type 2 diabetes mellitus; Impaired fasting glucose; Impaired glucose tolerance; Philippines epidemiology;
D O I
10.1016/j.diabres.2009.07.014
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims: Currently, there are no available data on the incidence of type 2 diabetes mellitus (T2DM) in the Philippines. A cohort derived from a national study population (FNRI-NNS, 1998) was revisited after 9 years to yield valuable data on glucose homeostasis among Filipinos. Methods: Six out of 13 national regions were included in the cohort. There were 1749 out of 2122 respondents (82.4%). 1386 (95.9%) consented to a fasting blood glucose (FBG) test, and 1275 (88.2%) completed the 2 h post-glucose (2HPG) load determination using whole blood capillary samples. Results: We observed a significant increase of mean FBGs (91.5 mg/dL to 103.3 mg/dL) from 1998 to 2007. The 9-year incidence of T2DM was 16.3%. The prevalence of T2DM was 28.0%. The prevalence of pre-diabetes, i.e., combined impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) was 31.3%; IFG was 17.S% and IGT was 23.9%. Conclusions: The study shows the alarming growth of diabetes, IFG, and IGT in our country that warrants early aggressive intervention for prevention and management. We encourage the use of 2 h post-glucose load aside from FBG in screening for true diabetics, IFGs, and IGTs. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:130 / 133
页数:4
相关论文
共 12 条
[1]
*CLIN GUID TASK FO, 2005, INT GUID TYP 2 DIAB
[2]
Dans A.L., 2005, Philippine Journal of Internal Medicine, V43, P103
[3]
DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group, 1998, BMJ, V317, P371
[4]
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 [J].
Mokdad, AH ;
Ford, ES ;
Bowman, BA ;
Dietz, WH ;
Vinicor, F ;
Bales, VS ;
Marks, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (01) :76-79
[5]
The continuing epidemics of obesity and diabetes in the United States [J].
Mokdad, AH ;
Bowman, BA ;
Ford, ES ;
Vinicor, F ;
Marks, JS ;
Koplan, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (10) :1195-1200
[6]
Reddy KS, 1998, CIRCULATION, V97, P596
[7]
SORIA MS, 2007, PHILIPP J INTERN MED
[8]
Sy RG, 2003, PHILIPP J INTERN MED, V41, P1
[9]
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030 [J].
Wild, S ;
Roglic, G ;
Green, A ;
Sicree, R ;
King, H .
DIABETES CARE, 2004, 27 (05) :1047-1053
[10]
World Health Organization, 1999, Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus, P1, DOI DOI 10.1002/(SICI)1096-9136(199807)15:7